Literature DB >> 28739441

Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller.

Jung-Jyh Hung1, Yi-Chen Yeh2, Yu-Chung Wu3, Teh-Ying Chou2, Wen-Hu Hsu3.   

Abstract

INTRODUCTION: The role of adjuvant chemotherapy for patients with stage I NSCLC remains unknown. The prognostic value of histological subtypes in resected node-negative small lung adenocarcinoma has not been widely investigated. This study investigated the prognostic factors in patients with node-negative lung adenocarcinoma 3 cm or smaller to find potential candidates for adjuvant chemotherapy.
METHODS: A total of 726 patients with completely resected node-negative lung adenocarcinoma 3 cm or smaller were included in the study. Prognostic factors for overall survival or probability of freedom from recurrence (FFR) were investigated.
RESULTS: During follow-up, recurrence developed in 59 patients (8.1%). Univariate analysis showed that the micropapillary/solid predominant pattern group was associated with a significantly lower probability of FFR (p = 0.001) in node-negative lung adenocarcinoma 3 cm or smaller. Those with greater tumor size (p = 0.001) and the micropapillary/solid predominant pattern group (p = 0.035) had a significantly lower probability of FFR in multivariate analysis. For tumors 2 cm or smaller, the micropapillary/solid predominant pattern group had a trend toward a lower probability of FFR (p = 0.053) in multivariate analysis. Presence of the solid pattern was a prognostic factor for lower probability of FFR (p = 0.001) in multivariate analysis.
CONCLUSIONS: The new adenocarcinoma classification has significant impact on recurrence in node-negative lung adenocarcinoma 3 cm or smaller. Patients with the micropapillary/solid predominant pattern have a significantly higher risk for recurrence. For tumors 2 cm or smaller, presence of the solid pattern was a prognostic factor for higher probability of recurrence. This information is useful for patient stratification for adjuvant therapy.
Copyright © 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant chemotherapy; Histological subtype; Lung adenocarcinoma; Recurrence

Mesh:

Year:  2017        PMID: 28739441     DOI: 10.1016/j.jtho.2017.07.009

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  11 in total

1.  Immunotherapy response modeling by ex-vivo organ culture for lung cancer.

Authors:  Iris Kamer; Elizabeta Bab-Dinitz; Oranit Zadok; Efrat Ofek; Teodor Gottfried; Inbal Daniel-Meshulam; Goni Hout-Siloni; Alon Ben Nun; Iris Barshack; Amir Onn; Jair Bar
Journal:  Cancer Immunol Immunother       Date:  2021-01-23       Impact factor: 6.968

2.  Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Platelet Count is Associated with the Rate of Lymph Node Metastasis in Lung Adenocarcinoma.

Authors:  Cheng-Hao Qu; Tong Li; Zhan-Peng Tang; Xi-Rui Zhu; Jing-Yi Han; Hui Tian
Journal:  Cancer Manag Res       Date:  2020-10-07       Impact factor: 3.989

4.  Prognosis of wide wedge resection in patients with stage IA1 and IA2 lung adenocarcinoma with total tumor size including the lepidic component greater than 2 cm: a single center retrospective study.

Authors:  Youngkyu Moon; Si Young Choi; Mi Hyoung Moon
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

5.  Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma.

Authors:  Yan Li; Yan Tan; Song Hu; Jun Xie; Zhantao Yan; Xian Zhang; Yun Zong; Han Han-Zhang; Qing Li; Chong Li
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

6.  [Pattern of Recurrence and Metastasis after Radical Resection of 
Non-small Cell Lung Cancer].

Authors:  Xianping Liu; Xiao Li; Fan Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-01-20

7.  Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism.

Authors:  Yuan Zhang; Zhongyue Shi; Jiawen Yi; Jin Zhao; Shu Zhang; Wei Feng; Min Zhu; Bin Hu; Yuhui Zhang
Journal:  Thorac Cancer       Date:  2021-12-04       Impact factor: 3.500

Review 8.  [Pathological and Molecular Features of Lung Micropapillary Adenocarcinoma].

Authors:  Jiafeng Liang; Qiong Wu; Shenglin Ma; Shirong Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-11-20

9.  Clinical implication of minimal presence of solid or micropapillary subtype in early-stage lung adenocarcinoma.

Authors:  Sun Ha Choi; Ji Yun Jeong; Shin Yup Lee; Kyung Min Shin; Shin Young Jeong; Tae-In Park; Young Woo Do; Eung Bae Lee; Yangki Seok; Won Kee Lee; Ji Eun Park; Sunji Park; Yong Hoon Lee; Hyewon Seo; Seung Soo Yoo; Jaehee Lee; Seung-Ick Cha; Chang Ho Kim; Jae Yong Park
Journal:  Thorac Cancer       Date:  2020-11-24       Impact factor: 3.223

10.  Different pathologic types of early stage lung adenocarcinoma have different post-operative recurrence patterns.

Authors:  Xianping Liu; Kunkun Sun; Fan Yang; Xizhao Sui; Guanchao Jiang; Jun Wang; Xiao Li
Journal:  Thorac Cancer       Date:  2021-06-28       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.